Judith Neuwahl, Chantal A Neumann, Annika C Fitz, Anica D Biermann, Maja Magel, Annabelle Friedrich, Lorenz Sellin, Björn Stork, Roland P Piekorz, Peter Proksch, Wilfried Budach, Reiner U Jänicke, Dennis Sohn
The targeted elimination of radio- or chemotherapy-induced senescent cells by so-called senolytic substances represents a promising approach to reduce tumor relapse as well as therapeutic side effects such as fibrosis. We screened an in-house library of 178 substances derived from marine sponges, endophytic fungi, and higher plants, and determined their senolytic activities towards DNA damage-induced senescent HCT116 colon carcinoma cells. The Pan-PI3K-inhibitor wortmannin and its clinical derivative, PX-866, were identified to act as senolytics...
May 29, 2024: Cell Death & Disease